AI makes ‘Centre for Sight’ Fastest most Accurate in LASIK Surgery

New Delhi: Always ahead of the curve, Centre for Sight, leader in advanced eye care in India, has introduced world fastest and safest AI enabled LASIK surgery technology AMARIS 1050 RS with FORESIGHT. This ground-breaking advancement revolutionizes vision correction by reducing treatment time to less than 10 seconds per eye,
enhancing precision, and optimizing patient outcomes.

With this launch, Centre for Sight introduces two more cutting-edge vision correction solutions—CustomEyes and SmartSurf ACE—both powered by FORESIGHT. CustomEyes: A highly personalized laser vision correction approach tailored to individual eye characteristics, ensuring optimized visual outcomes. SmartSurf ACE: A completely touch-free, blade-free LASIK laser procedure that enhances patient comfort, safety, and faster recovery.

These advanced procedures are powered by FORESIGHT, an AI- driven predictive system that enhances laser vision correction precision. FORESIGHT analyzes thousands of data points to customize treatment for every patient, allowing surgeons to foresee surgical outcomes before the procedure. This revolutionary integration ensures greater accuracy,
minimizes risks, and significantly improves visual outcomes.

Dr.Mahipal S Sachdev, Chairman and Medical Director, Centre for Sight, emphasized the significance of this breakthrough:“With myopia becoming a growing concern globally, studies suggest that by 2050, half of the world’s population will be myopic. At Centre for Sight, our focus is on providing advanced vision correction solutions to reduce dependency on glasses. The AMARIS 1050RS is the fastest and safest LASIK laser technology available today. It allows us to correct vision in just 10 seconds per eye, and the overall procedure takes only about 10 minutes. By combining advanced AI-driven eye tracking with high-speed LASIK laser treatment, we are ensuring that patients receive the fastest, safest, and most effective vision correction available today.

This advancement not only ensures greater precision and patient safety but also enables quicker recovery, helping people return to their daily routines with ease. Our commitment remains to bring the latest and most effective vision correction solutions to those who need them.” Mr. Dominic von Planta, CEO of Schwind Eye-Tech Solutions, added:“We celebrate installation of the Amaris 1050 at the Centre for Sight. The Amaris 1050 is the fastest excimer laser in the market, featuring a 7D eye-tracking system for exceptional precision and enhanced safety. Beyond being extremely fast and safe, it also enables CustomEyes with FORESIGHT, a personalized treatment approach
because every eye is unique.”

Centre for Sight has a longstanding history of introducing pioneering refractive technologies in India. It was the first to introduce SMILE (Small Incision Lenticule Extraction) technology in the country and played a pivotal role in developing SILK (Smooth Incision Lenticule Keratomileusis) surgery, transforming refractive eye care.

Between 2018 and 2023, Centre for Sight rigorously tested SILK through multiple clinical trials to ensure safety and effectiveness. Following successful trials, SILK was commercially launched in October 2023, marking a significant milestone in vision correction. Since then, Centre for Sight has performed the highest number of SILK in India, delivering exceptional visual outcomes and high patient satisfaction.

With myopia (nearsightedness) on the rise, these advanced LASIK laser correction technologies are set to redefine vision correction by providing safer, faster, and more effective solutions to reduce dependency on glasses or contact lenses.

  • Related Posts

    Yashoda Medicity Unveils T-Shirts & Finisher Medals ahead of Yashoda Half Marathon 4.0

    Over 4,000 participants are expected promoting overall health, preventive care & community fitness Ghaziabad: With physical inactivity emerging as an important public health concern, Yashoda Medicity, a leading hospital of…

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    PharmEasy, the online medical platform emphasizes the importance of early prevention and regular health screenings to reduce the risk of diabetes. By encouraging individuals to undergo timely blood sugar tests,…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Unveils T-Shirts & Finisher Medals ahead of Yashoda Half Marathon 4.0

    Yashoda Medicity Unveils T-Shirts & Finisher Medals ahead of Yashoda Half Marathon 4.0

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

    UP expands food, drug testing capacity across all 18 divisions

    UP expands food, drug testing capacity across all 18 divisions

    Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

    Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead